Latest AI and machine learning research in infectious disease for healthcare professionals.
The integration of artificial intelligence (AI) with Digital Twins (DTs) has emerged as a promising approach to revolutionize healthcare, particularly in terms of diagnosis and management of thoracic disorders. This study proposes a comprehensive framework, named Lung-DT, which leverages IoT sensors and AI algorithms to establish the digital representation of a patient's respiratory health. Using ...
BACKGROUND: The emergence and rapid spread of multi-drug resistant (MDR) bacterial strains, such as methicillin-resistant (MRSA) and vancomycin-resistant (VRSA), have posed a significant challenge to the medical community due to their ability to form biofilm and develop resistance to common antibiotics. Traditional antibiotics that were once effective in treating bacterial infections are now bec...
Predicting compound activity in assays is a long-standing challenge in drug discovery. Computational models based on compound-induced gene expression ...
BACKGROUND: Despite advances in clinical management, cytomegalovirus (CMV) infection remains a serious complication and an important cause of morbidit...
BACKGROUND: Bacterial vaginosis (BV) is a common clinical manifestation of a perturbed vaginal ecology associated with adverse sexual and reproductive...
The extracellular space (ECS) is an important barrier against viral attack on brain cells, and dynamic changes in ECS microstructure characteristics a...
INTRODUCTION: Artificial intelligence (AI) in healthcare can enhance clinical workflows and diagnoses, particularly in large-scale operations like COV...
Long COVID shares a number of clinical features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), including post-exertional malaise, s...
OBJECTIVES: Tuberculosis (TB) is a contagious illness caused by Mycobacterium tuberculosis. The initial symptoms of TB are similar to other respirator...
PURPOSE: Although several studies have compared the performance of deep learning (DL) models and radiologists for the diagnosis of COVID-19 pneumonia ...
The medical community does not broadcast the problem, but there are many studies that have reinforced a serious issue with diagnostic errors. A recent...
The advent of nanotechnology has been instrumental in the development of new drugs with novel targets. Recently, metallic nanoparticles have emerged a...
Discovery of small-molecule antibiotics with novel chemotypes serves as one of the essential strategies to address antibiotic resistance. Although a c...
The rising prevalence of antimicrobial resistance (AMR) of bacteria is a global health problem at the human, animal, and environmental interfaces, whi...
With the notable surge in therapeutic peptide development, various peptides have emerged as potential agents against virus-induced diseases. Viral ent...
Antimicrobial resistance is a global public health threat, and the World Health Organization (WHO) has announced a priority list of the most threateni...
The availability of target cells expressing the HIV receptors CD4 and CCR5 in genital tissue is a critical determinant of HIV susceptibility during se...
Identifying patients who may develop severe COVID-19 has been of interest to clinical physicians since it facilitates personalized treatment and optim...
BACKGROUND: The primary hurdle to curing HIV is due to the establishment of a reservoir early in infection. In an effort to find new treatment strateg...